The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

Rare Disorders NZ has fought for 300,000 Kiwis living with rare conditions, a group long overlooked by our healthcare system. As we reflect on our anniversary and th ...

Scientists used CRISPR gene editing to create a banana that stays yellow longer, reducing food waste and extending shelf life ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

What’s really exciting about gene editing is precision and speed, says Pairwise cofounder and CEO Tom Adams, PhD.

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Novo is paying up to $1 billion for a “non-incretin” medicine that might boost Wegovy’s effects. Elsewhere, Arbutus laid off ...

CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, ...

The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...